Biohaven Pharma (BHVN) Tops Q3 EPS by 24c

Biohaven Pharma (NYSE: BHVN) reported Q3 EPS of ($1.64), $0.24 better than the analyst estimate of ($1.88).

For earnings history and earnings-related data on Biohaven Pharma (BHVN) click here.

You May Also Be Interested In

• IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
• Broadcom results, guidance beat on soaring AI chip sales; stock slips after hours
• C3.ai (AI) Tops Q4 EPS by 5c, Beats on Revenue; Offers FY27 Revenue Guidance